Skip to content

Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire

Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04736641
Enrollment
105
Registered
2021-02-03
Start date
2021-03-01
Completion date
2022-09-01
Last updated
2021-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Disease, Hip Pain Chronic

Keywords

Hip disease, Reliability, Validity, Cross-cultural adaptation

Brief summary

The purpose of this study was to investigate adaptation, validity, and reliability of the Turkish version of the Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ).

Detailed description

There are a number of medical assessment tools for various diseases, but in most cases such tools are designed to reflect the perspective of healthcare providers, not perspective of patients. In addition to clinical results, it is necessary to evaluate the quality of life of patients when measuring the effect of medical treatments. Thus, evaluation criteria which can be useful as patient-reported outcome indices, have received increasing attention in recent years. Health-related quality of life provides a patient-reported assessment. Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) evaluates quality of life related to hip disorders. It is also a guide in determining the expectations of individuals in the treatment process. It consists of 3 subscales (pain, movement and mental) and 20 items. Hip condition and pain are evaluated with a 100 mm scale. 20 items are scaled likert with values between 0 and 4. 0 means strongly agree, 1 means agree, 2 means uncertain, 3 means disagree and 4 means strongly disagree. The study is planned with 105 individuals with hip disease. After questioning the sociodemographic characteristics of the individuals, the patients will be asked to fill in JOAHDEQ, Oxford Hip Score, International Hip Outcome Tool-12, Short Form-36, and Visual Analog Scale Test-retest will be re-applied to those of the same individuals who can be reached after 1 week. The results will be analyzed using the SPSS version 22.0 computer package program.

Interventions

OTHERSurvey study

Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ) will be applied

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Any diagnosed hip disease, * Chronic hip pain, * History of pain when lying or during weight-bearing activities, aggravated by activity for more than 3 months.

Exclusion criteria

* Lumbar spine nerve root findings, * History of lumbar spine or hip surgery, * Corticosteroid injection to hip in the past 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Japanese Orthopaedic Association Hip Disease Evaluation Questionnaire (JOAHDEQ)15 minutesJapanese Orthopaedic Association Hip Disease Evaluation Questionnaire is designed to evaluate quality of life related to hip disorders.

Countries

Turkey (Türkiye)

Contacts

Primary ContactHalime ARIKAN, MSc.
halimearikan92@gmail.com05465765132

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026